Porosome Therapeutics Inc., CSO presented at the recent (April 4-7, 2024) American Physiological Society Meetings in Long Beach, CA, studies on porosome reconstitution therapy that overcomes Cystic Fibrosis (CF) both in human bronchial epithelial cells and in CF mice.